Malignant hyperthermia: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(Started "See also")
mNo edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 2: Line 2:
'''Malignant hyperthermia''' is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."<ref>{{MeSH}}</ref>
'''Malignant hyperthermia''' is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."<ref>{{MeSH}}</ref>


==References==
==Diagnosis==
<references/>
Patients at risk of malignant hyperthermia can be identified with the caffeine halothane contracture test (CHCT) using biopsied muscle. This test is very [[sensitivity (tests)|sensitive]] but not [[specificity (tests)|specific]].
 
Genetic testing can identify approximately one individuals at risk and is very [[specificity (tests)|specific]].<ref name="titleFAQs - Molecular Genetic Testing for MH">{{cite web |url=http://medical.mhaus.org/index.cfm/fuseaction/Content.Display/PagePK/MolecularGeneticsFAQ.cfm |title=FAQs - Molecular Genetic Testing for MH |accessdate=2008-04-02 |author=Anonymous |authorlink= |coauthors= |date= |format= |work= |publisher=Malignant Hyperthermia Association of the United States |pages= |language= |archiveurl= |archivedate= |quote=}}</ref>


==See also==
==See also==
* [[Neuroleptic malignant syndrome]]
* [[Neuroleptic malignant syndrome]]
* [[Serotonin syndrome]]
* [[Serotonin syndrome]]
==References==
{{reflist}}[[Category:Suggestion Bot Tag]]

Latest revision as of 06:01, 15 September 2024

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Malignant hyperthermia is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."[1]

Diagnosis

Patients at risk of malignant hyperthermia can be identified with the caffeine halothane contracture test (CHCT) using biopsied muscle. This test is very sensitive but not specific.

Genetic testing can identify approximately one individuals at risk and is very specific.[2]

See also

References

  1. Anonymous (2024), Malignant hyperthermia (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Anonymous. FAQs - Molecular Genetic Testing for MH. Malignant Hyperthermia Association of the United States. Retrieved on 2008-04-02.